Logo
Haverhill Financial Research
Search
Log in
Subscribe free
Analysis
Portfolios
Portfolios

Model portfolios

Our best ideas, put together and explained

Portfolio builder

Pick your stocks, set your splits — live prices and exact share counts in seconds.

Watchlists
Watchlists

Weekly & mid-week watchlists

A new list every week, plus extras

The Haverhill Hundred

Our ranked top 100 stocks

News
News

News & commentary

The headlines that matter, and what they mean

The insider tracker

Live Form 4, 8-K and 13D/13G filings from 117 companies, in plain English

Amber
About
Logo
Haverhill Financial Research

Amber

Amber Watchlist: Portfolio Changes Preview

Watchlist

+1

Amber Watchlist: Portfolio Changes Preview

Where our model portfolios and our own research ratings disagree, and which positions are under review.

Oct 13, 2026

·

1 min read

Amber Watchlist: Pre-Earnings Setups

Watchlist

+2

LockSimple
Amber

Amber Watchlist: Pre-Earnings Setups

Twelve names we cover or hold report in the next three weeks. For each, what we would treat as a good quarter and what would worry us.

Oct 13, 2026

·

2 min read

NuScale Power (SMR): Haverhill Research Report

Amber

+2

LockSimple
Amber

NuScale Power (SMR): Haverhill Research Report

NuScale holds the only NRC-approved SMR design and $1.89B of cash, but no binding order yet. Rated Hold, Haverhill price target $7.60.

Oct 12, 2026

·

7 min read

Super Micro Computer (SMCI): Haverhill Research Report

Amber

+2

LockSimple
Amber

Super Micro Computer (SMCI): Haverhill Research Report

Super Micro's AI sales are soaring, but thin margins, cash burn and control weaknesses cap the upside. Rated Hold, Haverhill price target $43.

Oct 12, 2026

·

7 min read

Rigetti Computing (RGTI): Haverhill Research Report

Quantum

+2

LockSimple
Amber

Rigetti Computing (RGTI): Haverhill Research Report

A $4.8 billion quantum company with $5 million of quarterly revenue and years of cash. Rated Hold, Haverhill price target $12.

Oct 12, 2026

·

7 min read

Cloudflare (NET): Haverhill Research Report

Amber

+2

LockSimple
Amber

Cloudflare (NET): Haverhill Research Report

Cloudflare is growing faster as AI agents flood the web, but the shares already price that in. Rated Hold, Haverhill price target $345.

Oct 12, 2026

·

7 min read

Strategy (MSTR): Haverhill Research Report

Amber

+2

LockSimple
Amber

Strategy (MSTR): Haverhill Research Report

Bitcoin covers Strategy's debt and preferred 3.4 times, but the stock trades above what is left. Rated Hold, Haverhill price target $161.

Oct 12, 2026

·

7 min read

DraftKings (DKNG): Haverhill Research Report

Consumer

+2

LockSimple
Amber

DraftKings (DKNG): Haverhill Research Report

Predictions spending and thinner sports margins weigh on earnings, but the stock prices much of it in. Rated Hold, Haverhill price target $21.

Oct 12, 2026

·

7 min read

CoreWeave (CRWV): Haverhill Research Report

Amber

+2

LockSimple
Amber

CoreWeave (CRWV): Haverhill Research Report

CoreWeave's backlog passed $100 billion, but the debt paying for it is growing fast. Rated Hold, Haverhill price target $90.

Oct 12, 2026

·

7 min read

Circle (CRCL): Haverhill Research Report

Amber

+2

LockSimple
Amber

Circle (CRCL): Haverhill Research Report

USDC keeps growing, but lower rates and Coinbase payouts take much of the gain. Rated Hold, Haverhill price target $74.

Oct 12, 2026

·

7 min read

Arm Holdings (ARM): Haverhill Research Report

Amber

+2

LockSimple
Amber

Arm Holdings (ARM): Haverhill Research Report

Royalties are rising and Arm now sells its own chip, but the price already assumes 2031. Rated Hold, Haverhill price target $242.

Oct 12, 2026

·

6 min read

AppLovin (APP): Haverhill Research Report

Amber

+2

LockSimple
Amber

AppLovin (APP): Haverhill Research Report

Revenue up 53% with 84% margins, yet the stock trades near 15x 2027 earnings. Rated Buy, Haverhill price target $320.

Oct 12, 2026

·

7 min read

Amber Watchlist: Insider and Buyback Watch

Watchlist

+1

LockSimple
Amber

Amber Watchlist: Insider and Buyback Watch

Who sold without a plan, who bought with their own money, and which companies are buying back stock, across the names we cover and hold.

Oct 12, 2026

·

2 min read

Amber Watchlist: New Idea Pipeline

Watchlist

+1

LockSimple
Amber

Amber Watchlist: New Idea Pipeline

Five stocks we are researching now that could join the Haverhill Hundred or get a full report.

Oct 12, 2026

·

1 min read

Amber Watchlist: Ranks 31 to 100 Movers

Watchlist

+1

LockSimple
Amber

Amber Watchlist: Ranks 31 to 100 Movers

The paid-list names with the biggest moves over the past year, and whether each move changes its rank.

Oct 12, 2026

·

2 min read

Amber Watchlist: Binary-Event Playbook

Watchlist

+2

LockSimple
Amber

Amber Watchlist: Binary-Event Playbook

Three events that could move a covered stock by half in a day, and what each outcome would do to our value per share.

Oct 12, 2026

·

2 min read

Amber Watchlist: Quality on Sale

Watchlist

+1

LockSimple
Amber

Amber Watchlist: Quality on Sale

Nine Hundred Buys earning at least 17% on their capital whose shares have fallen 17% to 61% in a year.

Oct 12, 2026

·

2 min read

Amber Watchlist: Rating Changes on Deck

Watchlist

+1

LockSimple
Amber

Amber Watchlist: Rating Changes on Deck

The stocks closest to a Haverhill rating change, and the price or event that would trigger it. One is 3% away.

Oct 12, 2026

·

2 min read

Amber Watchlist: Above Our Price Target

Watchlist

+1

LockSimple
Amber

Amber Watchlist: Above Our Price Target

Four stocks we cover have run past what we think they are worth. Where we would get interested, for each one.

Oct 12, 2026

·

2 min read

Amber Watchlist: Below Our Price Target

Watchlist

+1

LockSimple
Amber

Amber Watchlist: Below Our Price Target

The covered stocks trading furthest under our 12-month targets, and the Hundred Buys we expect to put targets on next.

Oct 12, 2026

·

2 min read

Vertex: life after cystic fibrosis

Amber

+2

LockSimple
Amber

Vertex: life after cystic fibrosis

Cystic fibrosis still brings in 96% of sales. A pain pill, a gene therapy, a kidney drug decision on November 30 and a $10 billion acquisition are meant to change that. An Amber first look.

Oct 12, 2026

·

3 min read

Schwab: what higher rates are worth, and where client cash is going

Earnings

+3

LockSimple
Amber

Schwab: what higher rates are worth, and where client cash is going

Schwab earns about 3.8 points more on its assets than it pays on deposits. With the Fed raising rates again, an Amber first look ahead of Thursday's results.

Oct 12, 2026

·

3 min read

Intel: the turnaround now has three big shareholders and one big question

Amber

+2

LockSimple
Amber

Intel: the turnaround now has three big shareholders and one big question

The US government, Nvidia and SoftBank all bought in, and revenue is growing again. But the foundry business still has few outside customers. An Amber first look.

Oct 12, 2026

·

3 min read

Mastercard: what could actually slow the steadiest earner in payments?

Amber

+2

LockSimple
Amber

Mastercard: what could actually slow the steadiest earner in payments?

Revenue up 14%, a 61% margin and $4.9 billion of buybacks in a quarter. An Amber first look at the three threats Mastercard itself lists: regulation, stablecoins and the fight over fees.

Oct 12, 2026

·

3 min read

Oracle: $664 billion of orders, and the bill to deliver them

Amber

+2

LockSimple
Amber

Oracle: $664 billion of orders, and the bill to deliver them

Cloud infrastructure revenue more than doubled, but Oracle spent $28.5 billion on data centers in one quarter and is raising money to keep building. An Amber first look at the funding question.

Oct 12, 2026

·

3 min read

Haverhill Financial Research logo

Haverhill Financial Research

Analysis

Portfolios

Watchlists

The Haverhill Hundred

News

Amber

About Haverhill

Disclaimer

Haverhill Financial Research publishes general, impersonal financial research for educational purposes only. Nothing on this site or in our newsletters is personalized investment advice or a recommendation to buy or sell any security for your specific situation. Do your own research and consider consulting a licensed professional before investing. Authors may hold positions in securities discussed; positions are disclosed in each issue.

Questions or customer inquiries: [email protected]

© 2026 Haverhill Financial Research

© 2026 Haverhill Financial Research.
beehiivPowered by beehiiv